Your browser doesn't support javascript.
loading
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
Tarhini, Ahmad A; Lee, Sandra J; Hodi, F Stephen; Rao, Uma N M; Cohen, Gary I; Hamid, Omid; Hutchins, Laura F; Sosman, Jeffrey A; Kluger, Harriett M; Eroglu, Zeynep; Koon, Henry B; Lawrence, Donald P; Kendra, Kari L; Minor, David R; Lee, Carrie B; Albertini, Mark R; Flaherty, Lawrence E; Petrella, Teresa M; Streicher, Howard; Sondak, Vernon K; Kirkwood, John M.
Afiliación
  • Tarhini AA; H. Lee Moffitt Comprehensive Cancer Center, Tampa, FL.
  • Lee SJ; Harvard Medical School, Boston, MA.
  • Hodi FS; Dana-Farber Cancer Institute, Boston, MA.
  • Rao UNM; Dana-Farber Cancer Institute, Boston, MA.
  • Cohen GI; University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Hamid O; Greater Baltimore Medical Center, Baltimore, MD.
  • Hutchins LF; Angeles Clinic & Research Institute, Santa Monica, CA.
  • Sosman JA; University of Arkansas, Little Rock, AR.
  • Kluger HM; Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Eroglu Z; Yale University, New Haven, CT.
  • Koon HB; H. Lee Moffitt Comprehensive Cancer Center, Tampa, FL.
  • Lawrence DP; Case Western Reserve University, Cleveland, OH.
  • Kendra KL; Massachusetts General Hospital, Boston, MA.
  • Minor DR; Ohio State University, Columbus, OH.
  • Lee CB; Sutter-California Pacific Medical Center, San Francisco, CA.
  • Albertini MR; University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Flaherty LE; University of Wisconsin, Madison, WI.
  • Petrella TM; Wayne State University/Karmanos Cancer Institute, Detroit, MI.
  • Streicher H; Odette Cancer Center, Toronto, Ontario, Canada.
  • Sondak VK; National Cancer Institute, Rockville, MD.
  • Kirkwood JM; H. Lee Moffitt Comprehensive Cancer Center, Tampa, FL.
J Clin Oncol ; 38(6): 567-575, 2020 02 20.
Article en En | MEDLINE | ID: mdl-31880964
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Cutáneas / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Cutáneas / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article